Uncertainty in Biotech Patenting in Europe: Causes, Consequences and Possible Remedies
Rob Aerts
IP Director
Tigenix SAU
- Which regulatory body or bodies in Europe determines what is a patentable subject-matter and what is not?
- Examining the role of both EU law and EPC law
- Understanding why the systems sometimes collaborate and sometimes go in different directions
- How to take measures in regard to safeguard rights?